Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-14 Sale |
2023-09-18 7:03 pm |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
8,641 | $2.1017 | $18,161 | 2,403,882 (Direct) |
View |
| 2023-09-11 Sale |
2023-09-13 8:16 pm |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
27,917 | $2.2675 | $63,301 | 2,412,523 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-31 Option Award |
2025-04-02 09:06 am |
N/A 2035-03-31 |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President ,CEO & CMO |
918,308 | $0.98 | 918,308 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-23 4:33 pm |
N/A 2034-12-23 |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
1,135,000 | $0 | 1,135,000 (Direct) |
View |
| 2024-03-26 Option Award |
2024-03-28 4:33 pm |
N/A 2034-03-26 |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
1,071,242 | $3.83 | 1,071,242 (Direct) |
View |
| 2023-09-13 Tax Withholding |
2023-09-13 8:16 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
184,742 | $2.13 | 2,412,523 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 5:00 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
469,483 | $0 | 2,625,182 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:48 pm |
N/A 2031-03-30 |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
1,755,665 | $0 | 3,207,985 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 7:39 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
95,684 | $0 | 1,452,320 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-15 7:56 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
315,273 | $0 | 1,356,636 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
742,574 | $0 | 1,041,363 (Direct) |
View |
| 2021-10-07 Option Award |
2021-10-12 7:47 pm |
N/A 2031-10-07 |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
962,289 | $0 | 962,289 (Direct) |
View |
Ownership |
2021-10-07 9:28 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
0 | $0 | 1,351,075 (Direct) |
View |